Advanced search
Publication Cover
Nordic Journal of Psychiatry Volume 60, 2006 - Issue 2
Submit an article Journal homepage
64
Views
10
CrossRef citations to date
0
Altmetric
Original

Drug addiction in hepatitis C patients leads to a lower quality of life

Susanne Gjeruldsen Department of Infectious Diseases, Ullevål University Hospital.; Department of Behavioural Sciences in Medicine, University of Oslo.; Department of Infectious Diseases, Ullevål University Hospital.; Department of Psychiatry, Ullevål University Hospital.Correspondence[email protected]
,
Jon Håvard Loge Department of Infectious Diseases, Ullevål University Hospital.; Department of Behavioural Sciences in Medicine, University of Oslo.; Department of Infectious Diseases, Ullevål University Hospital.; Department of Psychiatry, Ullevål University Hospital.
,
Bjørn Myrvang Department of Infectious Diseases, Ullevål University Hospital.; Department of Behavioural Sciences in Medicine, University of Oslo.; Department of Infectious Diseases, Ullevål University Hospital.; Department of Psychiatry, Ullevål University Hospital.
&
Stein Opjordsmoen Department of Infectious Diseases, Ullevål University Hospital.; Department of Behavioural Sciences in Medicine, University of Oslo.; Department of Infectious Diseases, Ullevål University Hospital.; Department of Psychiatry, Ullevål University Hospital.
Pages 157-161 | Published online: 26 Aug 2009

References

  • Skretting A. Patterns on the European drug scene. An exploration of differences. Waal H, editor. Oslo: National Institute for Alcohol and Drug Research; 1998. p. 142–6.
  • Kielland KB, Siebke JC. Hepatitis A-, B- and C-markers among Norwegian drug addicts in the period 1975–89. Tidsskr Nor Laegeforen 1991; 111: 821–4
  • Gjeruldsen S, Abdelnoor M, Opjordsmoen S, Myrvang B. Death rates and causes of death in cohorts of serum hepatitis patients followed up for more than 20 years. Epidemiol Infect 2001; 126: 89–96
  • Benson G. Course and outcome of drug abuse and medical and social conditions in selected young drug abusers. Acta Psychiatr Scand 1985; 71: 48–66
  • Hammersley R, Lavelle TL, Forsyth AJ. Adolescent drug use, health and personality. Drug Alcohol Depend 1992; 31: 91–99
  • Holmberg MB. Longitudinal studies of drug abuse in a fifteen-year-old population. 4. Chronic drug abusers. Acta Psychiatr Scand 1985; 71: 201–3
  • Kokkevi A, Stefanis C. Drug abuse and psychiatric comorbidity. Compr Psychiatry 1995; 36: 329–37
  • Gjeruldsen S., Myrvang B, Opjordsmoen S. A 25-year follow-up study of drug addicts hospitalised for acute hepatitis. Present and past morbidity. Eur Addict Res 2003; 9: 80–6
  • Carithers RL, Jr, Sugano D, Bayliss M. Health assessment for chronic HCV infection: results of quality of life. Digest Dis Sci 1996; 41(12 Suppl)75S–80S
  • Ware JEJ, Bayliss MS, Mannocchia M, Davis GL. Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group. Hepatology 1999; 30: 550–5
  • Loge JH, Kaasa S. Short Form 36 (SF-36) health survey: normative data from the general Norwegian population. Scand J Soc Med 1998; 26: 250–8
  • Gjeruldsen S, Myrvang B, Opjordsmoen S. Risk factors for drug addiction and its outcome. A follow-up study over 25 years. Nord J Psychiatry 2003; 57: 373–6
  • Ware JE, Jr, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol 1998; 51: 903–12
  • Ware JEJ. Scoring the SF-36 Health Survey. SF-36 Health Survey. Manual & interpretation guide, JEJ Ware. Medical Outcomes Trust, Boston, MA 1997; 1–22
  • Loge JH, Kaasa S, Hjermstad MJ, Kvien TK. Translation and performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. I. Data quality, scaling assumptions, reliability, and construct validity. J Clin Epidemiol 1998; 51: 1069–76
  • Ware JE, Jr, Gandek B. Methods for testing data quality, scaling assumptions, and reliability: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 945–52
  • Altman DG, , editor. In: Practical statistics for medical research. London: Chapman and Hall; 1991. p. 194–244.
  • Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998; 27: 209–12
  • Rodger AJ, Jolley D, Thompson SC, Lanigan A, Crofts N. The impact of diagnosis of hepatitis C virus on quality of life. Hepatology 1999; 30: 1299–301
  • Wessely S, Pariante C. Fatigue, depression and chronic hepatitis C infection. Psychol Med 2002; 32: 1–10
  • Bonkovsky HL, Woolley JM. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group. Hepatology 1999; 29: 264–70

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.